Skip to content

Treatment of Alveolar Osteitis: Traditional or Regenerative?

A Clinical Investigation of the Efficacy of Platelet Rich Fibrin (Bio-PRF) Compared to Alveogyl in the Treatment of Alveolar Osteitis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05615272
Enrollment
58
Registered
2022-11-14
Start date
2022-10-01
Completion date
2024-07-31
Last updated
2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Osteitis, Dry Socket, Healing, Pain, Tooth Extraction

Brief summary

Alveolar osteitis, commonly referred to as dry socket, is a common painful postoperative complication following tooth extraction. It is defined as pain in and around an extraction socket which increases at any time between one and three days following extraction, accompanied by partial or total loss of the blood clot from the socket, with or without halitosis (Blum, 2002). The incidence of the complication varies from 1-5% for routine extractions up to approximately 30% for third molar extractions. There are a variety of factors that contribute to the incidence of dry socket including tissue trauma, smoking in the early postoperative period and the oral contraceptive pill. Although it is a self- limiting condition, symptoms can be very debilitating for patients and therefore following diagnosis, immediate treatment should be provided to expedite resolution and to their improve quality of life during the healing period. Treatment options for dry socket vary from rinsing of the socket, regular analgesia and sometimes placement of an obtundent, sedative dressing such as Alveogyl or a zinc oxide eugenol alternative. This study will aim to compare two treatments for patients who present with alveolar osteitis (dry socket) to Dublin Dental University Hospital after tooth extraction. Following randomisation, one of two treatment modalities will be used, either a experimental treatment (Bio-PRF) or a positive control (Alveogyl). The results of this study will enable us to learn more about the efficacy of these treatment options for dry socket and how they affect patients.

Interventions

BIOLOGICALBio-PRF

Intervention group

Control group

Sponsors

University of Dublin, Trinity College
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male and females adults at least 18 years old * A diagnosis of alveolar osteitis following tooth extraction based on patients having both pain and exposed bone * Good command of the English language * Willingness to keep a diary of symptoms and travel for the review appointment on day 7 following intervention

Exclusion criteria

* Pregnant or breastfeeding women * Current or previous bisphosphonate used or history of radiotherapy to the jaws * Allergy or intolerance to study materials * Lack of capacity to consent to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Change in postoperative pain levels: Day 0 to Day 3Day 3 following interventionPain will be measured using a pain diary with VAS scale (0-100) at baseline and Day 3. The changes in patient pain levels from baseline will be compared to Day 3 for each group.
Change in postoperative pain levels: Day 0 to Day 7Day 7 following interventionPain will be measured using a pain diary with VAS scale (0-100) at baseline and Day 7. The changes in patient pain levels from baseline will be compared to Day 7 for each group.

Secondary

MeasureTime frameDescription
HealingDay 7 following interventionHealing will be measured clinically by second blinded assessor using a modified version of the Landry Healing Index
Quality of Life Measurements (QoL)Day 7 following interventionThe patient's QoL will be assessed using a questionnaire modified from the postoperative symptom severity scale (PoSSe) ranging from 1-5, where 1 correlates to no impact on their quality of life and 5 signifies major impact on their quality of life. Higher scores will mean worse outcome if by Day 7, the patient's QoL scores remain high.

Countries

Ireland

Contacts

Primary ContactMaeve Cooney
maeve.cooney@dental.tcd.ie+353872529024

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026